education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Alzim
Alzim
donepezil
Manufacturer:
Fahrenheit
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Donepezil HCl
Indications/Uses
Symptomatic treatment of mild or moderate Alzheimer's dementia.
Dosage/Direction for Use
5 mg once daily before bedtime for 1 mth. After 1 mth, doses may be increased to 10 mg once daily. Max daily dose: 10 mg.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to piperadine derivatives.
Special Precautions
Sick sinus syndrome, conduction defects, asthma, COPD. Patients receiving NSAIDs. Pregnancy & lactation.
Adverse Reactions
Diarrhea, muscle cramps, weakness, nausea, vomiting, insomnia, dizziness. Mild increased blood creatinine-kinase level.
View
ADR Reporting Link
Drug Interactions
Anticholinergics, succinylcholine.
MIMS Class
Neurodegenerative Disease Drugs
ATC Classification
N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the management of dementia.
Regulatory Classification
K
Presentation/Packing
Form
Alzim tab 5 mg
Packing/Price
3 × 10's (Rp450,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk